AI assistant
Sending…
Monopar Therapeutics — Director's Dealing 2024
Jul 4, 2024
32883_dirs_2024-07-03_5b4cdce7-f054-4a61-b43a-a3b692afae51.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Monopar Therapeutics (MNPR)
CIK: 0001645469
Period of Report: 2024-07-01
Reporting Person: Radhakrishnan Karthik (Chief Financial Officer)
More from Monopar Therapeutics
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 14
Report Publication Announcement
2026
May 14
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 20
Annual Report
2026
Apr 1
Annual Report
2026
Mar 27
Director's Dealing
2026
Mar 4
Board/Management Information
2026
Mar 2